Baheal Group will bring IBM’s Watson for genomics to China

IBM Watson Health announced that Baheal Pharmaceutical Group will bring Watson for Genomics to clinicians across China. As IBM’s primary channel partner for Watson for Genomics in China, Baheal will establish an ecosystem within China to sell the molecular data interpretation technology to clinicians and researchers across the country. The new multi-year agreement comes less than three months after Baheal and IBM launched a strategic alliance to distribute Watson for Oncology in China.

[Read More]


The Pulse

The Pulse on Study Startup by Craig Morgan

Demand for Clinical Research Associates (CRAs), professionals whose main function is to monitor clinical trials, is expected to grow 1.52% annually by 2018, which results in many sponsors and CROs finding themselves in a never-ending recruitment cycle for qualified CRAs.

[Read More]

Clinical Intelligence

Awards & Advancement

JobWatch

Nasdaq GlobeNewswire